Skip to main content
. Author manuscript; available in PMC: 2015 Oct 13.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Apr 10;21(8):1460–1470. doi: 10.1016/j.bbmt.2015.04.009

Figure 2.

Figure 2

Cumulative incidences of mixed chimerism among patients with (A) differing alemtuzumab schedules, (B) HLA match, (C) stem cell source, and (D) underlying diagnosis.